IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Concord Biotech IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1551.00 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Citigroup Global Markets India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Concord Biotech IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th August 2022.
Concord Biotech IPO open date is 4th August 2023 and close date is 8th August 2023. IPO Allotment Date is 11th August 2023 and Listing date is 18th August 2023.
IPO
Size:
₹ 1551.00 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
71
City:
Ahmedabad
IPO so far:
31
Revenue (annualised):
₹
888.48
cr. 
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Concord Biotech IPO size is ₹ 1551.00 Cr. with IPO price of ₹ 741.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Citigroup Global Markets India Private Limited is the book-running lead manager of the Concord Biotech IPO. Link Intime India Private Limited is the Registrar for Concord Biotech IPO.
Concord Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Concord Biotech IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on biopharma company having many niche products. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Concord Biotech IPO size is ₹ 1551.00 Cr. with fresh issue size of ₹ 1551.00 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Concord Biotech IPO is expected to be 11th August 2023, after the finalization of basis of allotment. Investors can check Concord Biotech IPO allotment status on the registrars website, Link Intime India Private Limited . Concord Biotech IPO refund dates are 14th August 2023.
Concord Biotech IPO is expected to be listed on 18th August 2023.
The upper price band for the Concord Biotech IPO is set at ₹ 741.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Concord Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Concord Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 8th August 2023. After submission, funds are blocked until the basis of allotment of Concord Biotech IPO is finalised.
The merchant banker for Concord Biotech IPO is Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited . Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Concord Biotech IPO RHP for further details.
The registrar for Concord Biotech IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Concord Biotech IPO through their official website or helpline.
Concord Biotech IPO was subscribed 24.87 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1551.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
71
City:
Ahmedabad
IPO so far:
31
Revenue (annualised):
₹ 853.16 cr.
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Concord Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Concord Biotech Financial Review Page
Merchant Banker(s) of Concord Biotech IPO: Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Concord Biotech IPO subscription was 24.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Concord Biotech IPO listed at a listing price of 941.85 against the offer price of 741.00.
The current market price of Concord Biotech is 1926.60.
Why Us?
